199 related articles for article (PubMed ID: 35614147)
1. Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection.
Ribeiro Antinarelli LM; Glanzmann N; Mendonça DVC; Lage DP; Oliveira-da-Silva JA; Tavares GSV; Carvalho AMRS; Freitas CS; Martins VT; Duarte MC; Menezes-Souza D; da Silva AD; Coelho EAF; Soares Coimbra E
Parasitol Res; 2022 Jul; 121(7):2129-2140. PubMed ID: 35614147
[TBL] [Abstract][Full Text] [Related]
2. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
[TBL] [Abstract][Full Text] [Related]
3. Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Mendonça DVC; Tavares GSV; Pereira IAG; Oliveira-da-Silva JA; Ramos FF; Lage DP; Machado AS; Carvalho LM; Reis TAR; Carvalho AMRS; Ottoni FM; Ludolf F; Freitas CS; Martins VT; Chávez-Fumagalli MA; Duarte MC; Humbert MV; Roatt BM; Menezes-Souza D; Alves RJ; Coelho EAF
Exp Parasitol; 2022 Feb; 233():108205. PubMed ID: 34968460
[TBL] [Abstract][Full Text] [Related]
4. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Freitas CS; Oliveira-da-Silva JA; Lage DP; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Coelho VTS; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Humbert MV; Coimbra ES; Braga FC; Pádua RM; Coelho EAF
Parasitol Res; 2021 Jan; 120(1):321-335. PubMed ID: 33191446
[TBL] [Abstract][Full Text] [Related]
5. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA
Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599
[TBL] [Abstract][Full Text] [Related]
6. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
[TBL] [Abstract][Full Text] [Related]
7. Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Freitas CS; Lage DP; Machado AS; Vale DL; Martins VT; Cardoso JMO; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Ramos FF; Ludolf F; Pereira IAG; Bandeira RS; Fujiwara RT; Bueno LL; Roatt BM; Chávez-Fumagalli MA; Coelho EAF
Cytokine; 2023 Apr; 164():156143. PubMed ID: 36774730
[TBL] [Abstract][Full Text] [Related]
8. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Pereira IAG; Mendonça DVC; Tavares GSV; Lage DP; Ramos FF; Oliveira-da-Silva JA; Antinarelli LMR; Machado AS; Carvalho LM; Carvalho AMRS; Salustiano IV; Reis TAR; Bandeira RS; Silva AM; Martins VT; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Duarte MC; Menezes-Souza D; Coimbra ES; Leite JPV; Coelho EAF; Gonçalves DU
Parasite Immunol; 2020 Dec; 42(12):e12784. PubMed ID: 32772379
[TBL] [Abstract][Full Text] [Related]
9. Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Lage DP; Machado AS; Vale DL; Freitas CS; Linhares FP; Cardoso JMO; Pereira IAG; Ramos FF; Tavares GSV; Ludolf F; Oliveira-da-Silva JA; Bandeira RS; Silva AM; Simões LC; Reis TAR; Oliveira JS; Christodoulides M; Chávez-Fumagalli MA; Roatt BM; Martins VT; Coelho EAF
Cytokine; 2022 May; 153():155865. PubMed ID: 35339043
[TBL] [Abstract][Full Text] [Related]
10. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic
Mendonça DVC; Tavares GSV; Lage DP; Soyer TG; Carvalho LM; Dias DS; Ribeiro PAF; Ottoni FM; Antinarelli LMR; Vale DL; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
Biomed Pharmacother; 2019 Jan; 109():779-787. PubMed ID: 30551531
[TBL] [Abstract][Full Text] [Related]
11. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
[TBL] [Abstract][Full Text] [Related]
12. A clioquinol-containing Pluronic
Tavares GSV; Mendonça DVC; Pereira IAG; Oliveira-da-Silva JA; Ramos FF; Lage DP; Machado AS; Carvalho LM; Reis TAR; Perin L; Carvalho AMRS; Ottoni FM; Ludolf F; Freitas CS; Bandeira RS; Silva AM; Chávez-Fumagalli MA; Duarte MC; Menezes-Souza D; Alves RJ; Roatt BM; Coelho EAF
Parasite; 2020; 27():29. PubMed ID: 32351209
[TBL] [Abstract][Full Text] [Related]
13. Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
Machado AS; Lage DP; Vale DL; Freitas CS; Linhares FP; Cardoso JMO; Oliveira-da-Silva JA; Pereira IAG; Ramos FF; Tavares GSV; Ludolf F; Bandeira RS; Maia LGN; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Christodoulides M; Martins VT; Coelho EAF
Parasite Immunol; 2022 Aug; 44(8):e12921. PubMed ID: 35437797
[TBL] [Abstract][Full Text] [Related]
14. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Tavares GSV; Mendonça DVC; Miyazaki CK; Lage DP; Soyer TG; Carvalho LM; Ottoni FM; Dias DS; Ribeiro PAF; Antinarelli LMR; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
Parasitol Int; 2019 Feb; 68(1):63-72. PubMed ID: 30339837
[TBL] [Abstract][Full Text] [Related]
15. A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum.
Machado AS; Lage DP; Vale DL; Freitas CS; Linhares FP; Cardoso JMO; Pereira IAG; Ramos FF; Tavares GSV; Ludolf F; Oliveira-da-Silva JA; Bandeira RS; Simões AC; Duarte MC; Oliveira JS; Christodoulides M; Chávez-Fumagalli MA; Roatt BM; Martins VT; Coelho EAF
Acta Trop; 2022 Jun; 230():106412. PubMed ID: 35305943
[TBL] [Abstract][Full Text] [Related]
16. Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Pereira IAG; Freitas CS; Câmara RSB; Jesus MM; Lage DP; Tavares GSV; Soyer TG; Ramos FF; Soares NP; Santiago SS; Martins VT; Vale DL; Pimenta BL; Ludolf F; Oliveira FM; Duarte MC; Chávez-Fumagalli MA; Costa AV; Gonçalves DU; Roatt BM; Teixeira RR; Coelho EAF
Exp Parasitol; 2024 May; 260():108743. PubMed ID: 38513973
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
18. Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis.
Lage DP; Machado AS; Freitas CS; Vale DL; Linhares FP; Cardoso JMO; Oliveira-da-Silva JA; Ramos FF; Pereira IAG; Ludolf F; Tavares GSV; Bandeira RS; Oliveira JS; Menezes-Souza D; Duarte MC; Galdino AS; Christodoulides M; Chávez-Fumagalli MA; Roatt BM; Martins VT; Coelho EAF
Mol Immunol; 2023 Mar; 155():79-90. PubMed ID: 36731193
[TBL] [Abstract][Full Text] [Related]
19. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.
Lage LM; Barichello JM; Lage DP; Mendonça DV; Carvalho AM; Rodrigues MR; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Coelho EA; Duarte MC
Parasitol Res; 2016 Nov; 115(11):4083-4095. PubMed ID: 27365053
[TBL] [Abstract][Full Text] [Related]
20. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]